Why Pfizer Claims the Deal Evades Antitrust Review

Palantir lifted its 2025 revenue guidance and Pfizer has filed a second lawsuit against Novo Nordisk and obesity drug start-up Metsera. Plus, OpenAI inked a $38bn computing deal with Amazon, and the FT’s Claire Jones explains how the Trump administration is considering pushing for wider global dollar adoption. 

Mentioned in this podcast:

Palantir lifts 2025 sales outlook after posting strong quarterly growth

Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid

OpenAI strikes $38bn computing deal with Amazon

US pushes for wider global dollar adoption

Today’s FT News Briefing was produced by Sonja Hutson, and Marc Filippino. Our show was mixed by Kelly Garry. Additional help from Michela Tindera, Michael Lello and David da Silva. The FT’s acting co-head of audio is Topher Forhecz. The show’s theme music is by Metaphor Music.

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.